These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 2875664)

  • 1. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1986 Sep; 143(9):1162-5. PubMed ID: 2875664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.
    Waddington JL; Youssef HA; Dolphin C; Kinsella A
    Arch Gen Psychiatry; 1987 Oct; 44(10):907-12. PubMed ID: 2889438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
    Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?
    Waddington JL; O'Callaghan E; Larkin C; Kinsella A
    Brain Cogn; 1993 Sep; 23(1):56-70. PubMed ID: 8105822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset involuntary movements in chronic schizophrenia: relationship of 'tardive' dyskinesia to intellectual impairment and negative symptoms.
    Waddington JL; Youssef HA
    Br J Psychiatry; 1986 Nov; 149():616-20. PubMed ID: 2880630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1988 May; 145(5):613-6. PubMed ID: 2895985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia in chronic schizophrenic inpatients.
    Kua EH; Ang PC; Siew HC
    Singapore Med J; 1982 Feb; 23(1):19-21. PubMed ID: 6126008
    [No Abstract]   [Full Text] [Related]  

  • 9. Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.
    Gureje O
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1525-30. PubMed ID: 2906088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 12. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal involuntary movements in patients on long-acting neuroleptics.
    Oyewumi LK; Lapierre YD; Gray R; Batth S; Gelfand R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):719-23. PubMed ID: 6141614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to "tardive" dyskinesia independent of extent of neuroleptic medication.
    Reddi K
    Ir Med J; 1985 Sep; 78(9):270. PubMed ID: 2865231
    [No Abstract]   [Full Text] [Related]  

  • 16. Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to 'tardive' dyskinesia independent of extent of neuroleptic medication.
    Waddington JL; Youssef HA
    Ir Med J; 1985 May; 78(5):143-6. PubMed ID: 2861172
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective awareness of abnormal involuntary movements in schizophrenia.
    Sandyk R; Kay SR; Awerbuch GI
    Int J Neurosci; 1993; 69(1-4):1-20. PubMed ID: 7916006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.